Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

PURPOSE: We aimed to determine the amyloid (Aβ) and tau biomarker levels associated with imminent Alzheimer’s disease (AD) - related metabolic decline in cognitively normal individuals. METHODS: A threshold analysis was performed in 120 cognitively normal elderly individuals by modelling 2-year decl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Pascoal, Tharick A., Mathotaarachchi, Sulantha, Shin, Monica, Park, Ah Yeon, Mohades, Sara, Benedet, Andrea L., Kang, Min Su, Massarweh, Gassan, Soucy, Jean-Paul, Gauthier, Serge, Rosa-Neto, Pedro
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915512/
https://ncbi.nlm.nih.gov/pubmed/29396637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-3933-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados